EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, GeneOne Life Science's enterprise value is ₩196,767 Mil.
GeneOne Life Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩40,203 Mil. Therefore, GeneOne Life Science's EV-to-Revenue for today is 4.89.
The historical rank and industry rank for GeneOne Life Science's EV-to-Revenue or its related term are showing as below:
XKRX:011000'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.2 Med: 5.16 Max: 51.4
Current: 4.89
During the past 13 years, the highest EV-to-Revenue of GeneOne Life Science was 51.40. The lowest was 0.20. And the median was 5.16.
XKRX:011000's EV-to-Revenue is ranked better than 63.52% of 1039
companies
in the Biotechnology industry
Industry Median: 8.37
vs XKRX:011000: 4.89
GeneOne Life Science EV-to-Revenue Historical Data
The historical data trend for GeneOne Life Science's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GeneOne Life Science's EV-to-Revenue
For the Biotechnology subindustry, GeneOne Life Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GeneOne Life Science's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GeneOne Life Science's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where GeneOne Life Science's EV-to-Revenue falls into.
GeneOne Life Science's current Enterprise Value is ₩196,767 Mil.
GeneOne Life Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩40,203 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GeneOne Life Science (XKRX:011000) EV-to-Revenue Explanation
GeneOne Life Science's share price for today is ₩2375.00.
GeneOne Life Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩516.59.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GeneOne Life Science EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of GeneOne Life Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
GeneOne Life Science (XKRX:011000) Business Description
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:011000 has been successfully added to your 